Clinical trial

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

NCT04982705

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention [Part 1.1] IDG-16177 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part 1.1] Placebo of IDG-16177 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part 2] Sitagliptin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part1.2] IDG-16177 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part 2] IDG-16177 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part 1.2] Placebo of IDG-16177 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention [Part 2] Placebo of IDG-16177 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-07-07

PhasePHASE1

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

[Part 1.1] IDG-16177DRUG

[Part 1.1] Placebo of IDG-16177DRUG

[Part 2] SitagliptinDRUG

[Part1.2] IDG-16177DRUG

[Part 2] IDG-16177DRUG

[Part 1.2] Placebo of IDG-16177DRUG

[Part 2] Placebo of IDG-16177DRUG

Sponsors & collaborators

IlDong Pharmaceutical Co Ltdlead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04982705 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.